RxDoctor Payments Data

Anne Dunne

Family · Hillsboro, ORNPI 1255745204

Payments from drug & device makers

$599in general payments, 2019–2025

Across 51 payments — averaging $11.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$180
  • GSK$98
  • Merck$61
  • AbbVie$35
  • Pfizer$29
  • Exact Sciences$25
  • plus $172 from 10 others

What the payments were for

  • Food & beverage$599100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$599 in reported general payments places this provider in the 75th percentile of 1,130 family providers in Oregon.

See all family providers in Oregon

Medicare billing

Part B allowed, 2024
$40,483
Medicare patients
163
Services billed
1,220

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban67$60,238
JardianceEmpagliflozin42$54,687
Trelegy ElliptaFluticasone/Umeclidin/Vilanter39$38,769
JanuviaSitagliptin Phosphate33$33,662
MyrbetriqMirabegron23$22,376
OzempicSemaglutide18$15,049
FarxigaDapagliflozin Propanediol17$14,245
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$11,149
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr17$8,700
Breo ElliptaFluticasone/Vilanterol16$7,490
SymbicortBudesonide/Formoterol Fumarate16$6,466
Fluvoxamine Maleate ErFluvoxamine Maleate13$6,160
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate15$5,442
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$4,454
Gabapentin203$3,696

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$29$60,23867 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$98$54,95972 claims
MerckJanuvia$61$33,66233 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$13$31,86044 claims
Novo NordiskOzempic$17$15,04918 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,130 family providers in Oregon.

Other family in Hillsboro

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →